Figure 3.
Immune checkpoints and small molecular drugs in ovarian cancer. (A) Box plots for the associations between subtypes and immune checkpoints in ovarian cancer. Ns, not significant; **p < 0.01; ***p < 0.001. (B) Heatmap showing small inhibitors (perturbagen) and their shared mechanisms of action (rows) from the CMap database.